Atlas Trials

p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

Clinical trial NCT02435186 · UNKNOWN

Trial details

NCT number
NCT02435186
Sponsor
Shenzhen SiBiono GeneTech Co.,Ltd
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Epithelial CancerFallopian Tube CancerPrimary Peritoneal Cancer
Start date
2015-06-01
Primary completion
2018-08-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.